endTB organization

PIH and PIH-affiliated clinicians discuss the case of the first patient in Kazakhstan to receive a new treatment regimen that includes Bedaquiline. (Photo by Askar Yedilbayev / Partners In Health)
PIH and PIH-affiliated clinicians discuss the case of the first patient in Kazakhstan to receive a new treatment regimen that includes Bedaquiline. (Photo by Askar Yedilbayev / Partners In Health)

Project Leaders 

  • Dr. Aamir Khan (Interactive Research & Development)
  • Dr. Michael Rich (Partners In Health)
  • Dr. KJ Seung (Partners In Health)

  • Dr. Francis Varaine (Médecins Sans Frontières)

For bios of the endTB project leaders, see the Leadership page.

Observational Study (Output 1) Principal Investigators

  • Dr. Helena Huerga (Epicentre)
  • Dr. Uzma Khan (Interactive Research & Development)
  • Dr. KJ Seung (Partners In Health)

Clinical Trial (Output 2) Principal Investigators

  • Dr. Carole Mitnick (Harvard Medical School) 
  • Dr. Lorenzo Guglielmetti (Médecins sans Frontières)

Clinical Trial (Output 2) Co-Investigators 

  • Elisabeth Baudin (Epicentre)
  • Dr. Maryline Bonnet (Epicentre)
  • Dr. Bouke de Jong (Antwerp Institute of Tropical Medicine) 
  • Dr. Michael Rich (Partners In Health)
  • Dr. Alex Telnov (Médecins sans Frontières)
  • Dr. Francis Varaine (Médecins sans Frontières)
  • Dr. Gabriella Ferlazzo (Médecins sans Frontières)
  • Dr. Gustavo Velásquez (Harvard Medical School)
PIH MSF MSF UNITAID